InsidersTradesSigma
Follow the Diaceutics PLC share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares trade on the UK market, under the supervision of RNS (LSE). Market capitalisation: €126.1m. The latest transaction was disclosed on 7 March 2024 (Purchase). Among the most active insiders: Graham Patterson. All data is openly available.
Analysts rate Diaceutics PLC Strong Buy (bullish), based on 5 analysts. Average price target: £213.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Diaceutics PLC is a company specializing in health data analytics, aiming to improve patient outcomes through personalized treatments. It primarily operates in the UK market and focuses on optimizing diagnostic testing.